Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Eur Neuropsychopharmacol. 2012 Nov 21;23(8):852–864. doi: 10.1016/j.euroneuro.2012.10.006

Table 1.

[3H]Ketanserin binding displacement curves by DOI in frontal cortex membrane preparations of antipsychotic-free (AP-F) schizophrenics, antipsychotic-treated (AP-T) schizophrenics, and controls.

Control Schizophrenia(AP-F) Control Schizophrenia (AP-T)

log Ki-high −10.21 ± 0.32 −10.20 ± 0.15*** −10.78 ± 0.33 −10.53 ± 0.33*,+
Fraction high (%) 5.51 ± 1.06 10.34 ± 0.88*** −05.75 ± 1.01 8.76 ± 1.51*,+
log Ki-medium −7.70 ± 0.05 −7.55 ± 0.03*** 0-7.69 ± 0.04 −7.56 ± 0.07*,+
Fraction medium (%) 72.5 ± 5.31 73.8 ± 1.68*** --78.0 ± 2.74 75.2 ± 4.20*,+
log Ki-low −6.25 ± 0.16 −5.91 ± 0.19*** 0-6.06 ± 0.23 −5.94 ± 0.37*,+
*

p<0.05;

***

p<0.001 when compared with individually matched control subjects by Student’s t-test.

+

p<0.05 when compared with antipsychotic-free schizophrenic subjects by Student’s t-test.

Data were best fit to a triphasic compared to biphasic displacement curve by F-test (p<0.0001).

See Supplementary Tables 1 and 2 for demographic information. All values represent means ± SEM.